Literature DB >> 9166201

Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study.

J Mant1, R Painter, M Vessey.   

Abstract

OBJECTIVE: To explore the epidemiology of uterovaginal and post-hysterectomy prolapse.
DESIGN: Cohort study.
SETTING: Seventeen large family planning clinics in England and Scotland. POPULATION: 17,032 women who attended family planning clinics between 1968 and 1974, aged between 25 and 39 years at study entry.
METHODS: Annual follow up by interview, postal or telephone questionnaire until July 1994. Further details on all hospital admissions were obtained from the hospital discharge summaries. All women were flagged at time of recruitment in the NHS central registers. MAIN OUTCOME MEASURE: In-patient admission with diagnosis of prolapse (ICD codes 8th Revision 623.0-623-9).
RESULTS: The incidence of hospital admission with prolapse is 2.04 per 1000 person-years of risk. Age, parity, calendar period and weight were significantly associated with risk of an inpatient admission with prolapse after adjustment for principal confounding factors. Significant trends were observed with regard to smoking status and obesity (Quetelet Index) at entry to the study and risk of prolapse. Social class, oral contraceptive use and height were not significantly associated with risk of prolapse. The incidence of prolapse which required surgical correction following hysterectomy was 3.6 per 1000 person-years of risk. The cumulative risk rises from 1% three years after a hysterectomy to 5% 15 years after hysterectomy. The risk of prolapse following hysterectomy is 5.5 times higher (95% CI 3.1-9.7) in women whose initial hysterectomy was for genital prolapse as opposed to other reasons.
CONCLUSION: Among the potential risk factors that were investigated, parity shows much the strongest relation to prolapse.

Entities:  

Mesh:

Year:  1997        PMID: 9166201     DOI: 10.1111/j.1471-0528.1997.tb11536.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  158 in total

Review 1.  Informed consent for obstetrics management: a urogynecologic perspective.

Authors:  G W Davila
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

Review 2.  Management of genital prolapse.

Authors:  Ranee Thakar; Stuart Stanton
Journal:  BMJ       Date:  2002-05-25

3.  "Mommy, how will the baby get out of your tummy? Will it hurt you?"

Authors:  John O L DeLancey
Journal:  Am J Obstet Gynecol       Date:  2017-08       Impact factor: 8.661

4.  Levator ani muscle stretch induced by simulated vaginal birth.

Authors:  Kuo-Cheng Lien; Brian Mooney; John O L DeLancey; James A Ashton-Miller
Journal:  Obstet Gynecol       Date:  2004-01       Impact factor: 7.661

5.  The appearance of levator ani muscle abnormalities in magnetic resonance images after vaginal delivery.

Authors:  John O L DeLancey; Rohna Kearney; Queena Chou; Steven Speights; Shereen Binno
Journal:  Obstet Gynecol       Date:  2003-01       Impact factor: 7.661

6.  Effects of voluntary pelvic floor contraction and relaxation on the urethral closure pressure.

Authors:  Kaven Baessler; Kirstin Miska; Ruth Draths; Bernhard Schuessler
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-09-22

Review 7.  Genital prolapse in women.

Authors:  Joseph Loze Onwude
Journal:  BMJ Clin Evid       Date:  2012-03-14

Review 8.  Vaginal delivery and pelvic floor dysfunction: current evidence and implications for future research.

Authors:  M A T Bortolini; H P Drutz; D Lovatsis; M Alarab
Journal:  Int Urogynecol J       Date:  2010-05-06       Impact factor: 2.894

9.  Vaginal parity and pelvic organ prolapse.

Authors:  Lieschen H Quiroz; Alvaro Muñoz; Stuart H Shippey; Robert E Gutman; Victoria L Handa
Journal:  J Reprod Med       Date:  2010 Mar-Apr       Impact factor: 0.142

10.  Variables Affecting Intra-abdominal Pressure During Lifting in the Early Postpartum Period.

Authors:  Yvonne Hsu; Robert Hitchcock; Stefan Niederauer; Ingrid E Nygaard; Janet M Shaw; Xiaoming Sheng
Journal:  Female Pelvic Med Reconstr Surg       Date:  2018 Jul/Aug       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.